Humacyte, Inc.
HUMA
$1.29
$0.032.38%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 75.82% | 58.00% | 26.52% | -34.24% | -71.01% |
| Total Depreciation and Amortization | 2.08% | 1.09% | -2.77% | -6.85% | -9.81% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -100.00% |
| Total Other Non-Cash Items | -218.73% | -202.26% | -273.14% | 89.78% | 718.09% |
| Change in Net Operating Assets | -395.88% | -204.90% | -321.88% | -95.27% | 336.99% |
| Cash from Operations | -16.44% | -29.49% | -21.17% | -33.85% | -23.75% |
| Capital Expenditure | 45.27% | -47.21% | 7.24% | 31.05% | 40.98% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -100.00% |
| Cash from Investing | 45.27% | -47.21% | -339.63% | -808.67% | -131.97% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -13.47% | -13.85% | 92.20% | 92.43% | 92.66% |
| Issuance of Common Stock | 138.17% | 127.49% | 125.50% | 16,656.54% | 7,158.97% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -339.51% | -88.54% | -96.69% | -42.33% | -46.32% |
| Cash from Financing | -11.97% | 64.56% | 44.92% | 2,433.46% | 1,257.28% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -73.66% | 73.26% | 80.62% | 121.01% | 53.60% |